Ipilimumab vs Metoprolol
Ipilimumab vs Metoprolol: Overview
This comparison examines the pharmacological differences between Ipilimumab and Metoprolol.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Metoprolol: Selective beta-1 adrenergic receptor blocker.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Metoprolol β 3-7 hours.
Chemical Properties
Molecular Formula: Metoprolol β C15H25NO3.
Molecular Weight: Metoprolol β 267.3640 g/mol.
Type: Ipilimumab β Antibody; Metoprolol β Small molecule.